Frankfurt - Delayed Quote EUR
Immatics N.V. (4A3.F)
3.9300
+0.0820
+(2.13%)
As of 8:02:51 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
155,835
155,835
53,997
172,831
34,763
Operating Expense
194,450
194,450
155,722
142,877
121,057
Operating Income
-38,615
-38,615
-101,725
29,954
-86,294
Net Non Operating Interest Income Expense
24,115
24,115
13,014
1,438
-433
Other Income Expense
35,846
35,846
-8,283
10,644
-6,608
Pretax Income
21,346
21,346
-96,994
42,036
-93,335
Tax Provision
6,128
6,128
-2,345
14,333
--
Net Income Common Stockholders
15,218
15,218
-94,649
27,703
-93,335
Diluted NI Available to Com Stockholders
15,218
15,218
-94,649
27,703
-93,335
Basic EPS
0.14
--
-1.18
0.41
-1.48
Diluted EPS
0.14
--
-1.18
0.40
-1.48
Basic Average Shares
105,744.9290
--
80,546.6820
67,220.8240
62,912.9210
Diluted Average Shares
106,795.1000
--
80,546.6820
68,824.9060
62,912.9210
Total Operating Income as Reported
-38,615
-38,615
-101,725
29,954
-86,294
Total Expenses
194,450
194,450
155,722
142,877
121,057
Net Income from Continuing & Discontinued Operation
15,218
15,218
-94,649
27,703
-93,335
Normalized Income
-10,337.3466
-10,337.3466
-86,566.2560
20,688.2809
-86,727
Interest Income
25,001
25,001
13,845
2,476
133
Interest Expense
886
886
831
1,038
566
Net Interest Income
24,115
24,115
13,014
1,438
-433
EBIT
22,232
22,232
-96,163
43,074
-92,769
EBITDA
34,457
34,457
-88,929
50,041
-87,509
Reconciled Depreciation
12,225
12,225
7,234
6,967
5,260
Net Income from Continuing Operation Net Minority Interest
15,218
15,218
-94,649
27,703
-93,335
Total Unusual Items Excluding Goodwill
35,846
35,846
-8,283
10,644
-6,608
Total Unusual Items
35,846
35,846
-8,283
10,644
-6,608
Normalized EBITDA
-1,389
-1,389
-80,646
39,397
-80,901
Tax Rate for Calcs
0.0003
0.0003
0
0.0003
--
Tax Effect of Unusual Items
10,290.6534
10,290.6534
-200.2560
3,629.2809
--
12/31/2021 - 7/8/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
23J0.F ProMIS Neurosciences, Inc.
0.5150
-4.63%
M8W.F MediWound Ltd.
15.60
+0.65%
DRUG.CN Bright Minds Biosciences Inc.
47.48
0.00%
ANEB Anebulo Pharmaceuticals, Inc.
0.9950
+2.58%
SRZN Surrozen, Inc.
9.95
+0.70%
PYPD PolyPid Ltd.
2.6600
-3.27%
BNTC Benitec Biopharma Inc.
14.09
+3.15%
PMVP PMV Pharmaceuticals, Inc.
1.0700
0.00%
PVLA Palvella Therapeutics, Inc.
26.30
-0.99%
ELDN Eledon Pharmaceuticals, Inc.
3.3200
-1.19%